Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Skin changes in diabetes mellitus].

M Meurer1, M Stumvoll, R-M Szeimies

  • 1Klinik und Poliklinik für Dermatologie, Universitätsklinikum Carl Gustav Carus, Dresden. Meurer@rcs.urz.tu-dresden.de

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|April 15, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Phototesting in dermatology].

Dermatologie (Heidelberg, Germany)·2026
Same author

Long-term follow-up of a randomized, double-blind, phase III, multi-centre study to evaluate the safety and efficacy of field-directed photodynamic therapy (PDT) of mild to moderate actinic keratosis using BF-200 ALA versus placebo and the BF-RhodoLED® lamp.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

High efficacy of red light photodynamic therapy with 10 % aminolevulinic acid gel irrespective of the extent of keratinocyte atypia in actinic keratosis - exploratory post-hoc analysis of three pivotal phase III trials.

Photodiagnosis and photodynamic therapy·2024
Same author

[Treatment of actinic keratoses in older adults].

Dermatologie (Heidelberg, Germany)·2023
Same author

Pharmacokinetic profile data of glycopyrronium bromide 1% cream beyond 2 weeks are important: reply from the authors.

The British journal of dermatology·2021
Same author

A glycopyrronium bromide 1% cream for topical treatment of primary axillary hyperhidrosis: efficacy and safety results from a phase IIIa randomized controlled trial.

The British journal of dermatology·2021

Diabetes mellitus, a common metabolic disorder, affects nearly 5 million in Germany. Skin changes, including infections and complications, can appear even in the prediabetic stage.

Area of Science:

  • Endocrinology and Metabolism
  • Dermatology
  • Public Health

Context:

  • Diabetes mellitus is a prevalent metabolic disorder, impacting a significant portion of the German population (nearly 5 million individuals).
  • The disease encompasses four main types: type 1, type 2, gestational diabetes, and other specific forms.
  • Manifestations, such as skin changes, can be observed even in the prediabetic stage, highlighting the importance of early detection.

Purpose:

  • To outline the classification of diabetes mellitus and its commonality in Germany.
  • To emphasize that skin alterations can be early indicators of diabetes, appearing in the prediabetic phase.
  • To categorize the diverse skin changes associated with diabetes mellitus.

Summary:

  • Diabetes mellitus is the most frequent metabolic disorder, with nearly 5 million affected in Germany.

Related Experiment Videos

  • Skin changes related to diabetes are categorized into four groups: infections, frequently associated dermatoses, complications-related alterations, and treatment reactions.
  • These dermatological signs can manifest early, even during the prediabetic stage of limited glucose tolerance.

    • Impact:

    • Highlights the broad impact of diabetes mellitus, extending to dermatological manifestations.
    • Underscores the potential for early diagnosis of diabetes through the recognition of specific skin changes.
    • Provides a framework for understanding and managing the cutaneous complications of diabetes.